- Home
- products
- palestinian territories
- biopsy testing
Refine by
Biopsy Testing Equipment & Supplies In Palestinian Territories
12 equipment items found
Manufactured by:Epigenomics AG based inBerlin, GERMANY
Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi proColon® offers a convenient way of detecting colorectal cancer: in blood. It’s as simple as a blood draw. The test is performed by a clinical ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
AlphaLiquid® Detect is an industry-first tumor-informed, hybrid-capture NGS-based liquid biopsy test designed for MRD detection and recurrence monitoring in stage I-III solid tumor patients. The assay incorporates a personalized panel of up to 1,000 targets, including both tumor-informed patient-specific markers as well as additional therapeutic targets. ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
OncoFOLLOW: The first personalised liquid biopsy in the market. Monitor the progression and detect lack of response. OncoFOLLOW is a test based on the analysis of circulating tumor DNA in blood. It is used to monitor the progression of the tumor (burden of the disease) and to detect lack of response or resistance to treatment as soon as it appears. ...
Manufactured by:OTraces Inc. based inSykesville, MARYLAND (USA)
TME Liquid Biopsy Dx immunoassay test for assessing progression of low Gleason Score prostate cancer to high Gleason Score aggressive prostate cancer, Active ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Manufactured by:Guardant Health, Inc. based inRedwood City, CALIFORNIA (USA)
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects circulating tumor DNA (ctDNA) in blood after surgery to identify patients with residual disease who may benefit most from adjuvant therapy. ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
The 4Kscore® Test is used by health care professionals to improve the accuracy of prostate cancer diagnosis after an abnormal prostate-specific antigen (PSA) test result, or digital rectal exam, before the decision is made to biopsy. The 4Kscore® Test provides a risk score (4KScore) for finding aggressive prostate cancer ...
Manufactured by:Villa Sistemi Medicali Spa based inBuccinasco (MI), ITALY
The completely redesigned Melody III mammography line is the best the new technologies and Villa’s experience in mammography can offer. Every aspect of the X-ray examination and every characteristic of the mammography unit have been reviewed in depth, making improvements to increase patient comfort and the examination speed and achieving even greater diagnostic accuracy and operational ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers. The initial test delivered by the miR Disease Management Platform® is the miR Sentinel™ Prostate Cancer Test, the first and only standalone, non-invasive liquid ...
Manufactured by:Amadix based inValladolid, SPAIN
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of individuals with Lung ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when ...